Product image of Latanoprost Stada (Latanoprost) supplied by GNH India

Latanoprost Stada

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Stada (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Stada, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for primary open‑angle glaucoma and ocular hypertension in adult patients.
GNH India supplies Latanoprost Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intra‑ocular pressure.
  • Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression.
  • Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma.

How It Works

  • Latanoprost binds to prostaglandin F (FP) receptors in the ciliary body, activating a cascade that remodels extracellular matrix and increases uveoscleral outflow of aqueous humor. The enhanced outflow reduces intra‑ocular pressure, helping to protect the optic nerve from pressure‑related damage.

Side Effects

Latanoprost may cause ocular and peri‑ocular reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness or hyperemia: mild irritation of conjunctival vessels.
  • Increased eyelash growth: longer, thicker lashes.
  • Iris pigmentation change: gradual darkening of eye color.
  • Eye irritation or foreign body sensation.
  • Blurred vision: transient after instillation.
  • Periorbital skin darkening.

Serious or Rare Side Effects

  • Severe ocular inflammation (uveitis, iritis).
  • Allergic contact dermatitis of the eyelid.
  • Sudden loss of vision or visual field defects.
  • Corneal edema or endothelial decompensation.
  • Persistent ocular pain or photophobia.
  • Systemic hypersensitivity reactions.

Precautions & Warnings

  • Before using Latanoprost, patients and clinicians should consider the following safety points.
  • Monitor intra‑ocular pressure: ensure target pressure is achieved and maintained.
  • Avoid contact lens wear for at least 15 minutes after instillation to prevent lens contamination.
  • Assess for active ocular infection or inflammation: defer use until resolved.
  • Use with caution in patients with a history of cystoid macular edema.
  • Discontinue if severe ocular inflammation or allergic reaction occurs.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ocular or systemic agents, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Concurrent use of other prostaglandin analog eye drops: may increase risk of ocular hyperemia and pigmentary changes.
  • Use with ocular inflammation‑inducing agents (e.g., certain steroids): can exacerbate inflammation.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory eye drops: may alter ocular surface tolerance.
  • Systemic beta‑blockers: monitor blood pressure and heart rate when combined with other IOP‑lowering drugs.
  • CYP450 inhibitors (e.g., ketoconazole): may affect systemic clearance of latanoprost metabolites.
  • Anticholinergic eye drops: monitor for additive pupil dilation effects.

Frequently Asked Questions

Latanoprost Stada is an ophthalmic solution containing the prostaglandin analog latanoprost. It is prescribed to lower intra‑ocular pressure in adults with primary open‑angle glaucoma or ocular hypertension, helping to prevent optic nerve damage and preserve visual function.

Latanoprost binds to prostaglandin F (FP) receptors in the eye’s ciliary body, triggering a biochemical cascade that remodels extracellular matrix. This remodeling increases the uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure.

The dosing regimen for Latanoprost Stada is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

The safety of latanoprost in pregnancy or while breastfeeding has not been definitively established. Healthcare providers should weigh potential benefits against unknown risks and consider alternative treatments if appropriate.

To request Latanoprost Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker drops, latanoprost often has a more favorable systemic safety profile, though it may cause ocular pigment changes that are less common with other classes.

Latanoprost Stada should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from light and moisture, and keep the cap tightly closed when not in use to maintain product stability.

Latanoprost Stada is administered as a single drop placed in the conjunctival sac of the affected eye(s) once daily, preferably in the evening. Patients should avoid touching the tip of the bottle to the eye or any surface to maintain sterility.

Serious risks, though rare, include severe ocular inflammation such as uveitis or iritis, allergic reactions affecting the eyelids or surrounding skin, and sudden loss of vision. Any abrupt visual changes or intense eye pain should prompt immediate medical evaluation.

Latanoprost Stada is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and in eyes with active intra‑ocular inflammation or infection. Caution is also advised for individuals with a history of cystoid macular edema.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT